+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019

  • ID: 4861030
  • Report
  • November 2019
  • Region: Global
  • 132 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Abbott Diagnostics
  • Bioprognos SL
  • Fujirebio Diagnostics Inc
  • IntegraGen SA
  • Oncimmune (USA) LLC
  • Proteome Sciences Plc
  • MORE
Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019

Summary

The Publisher's Medical Devices sector report, “Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019" provides an overview of Liver Cancer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Liver Cancer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by the Publisher's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Liver Cancer Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Liver Cancer Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Liver Cancer Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Diagnostics
  • Bioprognos SL
  • Fujirebio Diagnostics Inc
  • IntegraGen SA
  • Oncimmune (USA) LLC
  • Proteome Sciences Plc
  • MORE
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Liver Cancer Diagnostic Tests Overview

3 Products under Development
3.1 Liver Cancer Diagnostic Tests - Pipeline Products by Stage of Development
3.2 Liver Cancer Diagnostic Tests - Pipeline Products by Territory
3.3 Liver Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
3.4 Liver Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
3.5 Liver Cancer Diagnostic Tests - Ongoing Clinical Trials

4 Liver Cancer Diagnostic Tests - Pipeline Products under Development by Companies
4.1 Liver Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development
4.2 Liver Cancer Diagnostic Tests - Pipeline Products by Stage of Development

5 Liver Cancer Diagnostic Tests Companies and Product Overview
5.1 Abbott Diagnostics Company Overview
5.1.1 Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
5.2 Abcodia Ltd Company Overview
5.2.1 Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.3 AXO Science SAS Company Overview
5.3.1 AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview
5.4 BioMark Technologies Inc Company Overview
5.4.1 BioMark Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 Bioprognos SL Company Overview
5.5.1 Bioprognos SL Pipeline Products & Ongoing Clinical Trials Overview
5.6 China Sky One Medical Inc Company Overview
5.6.1 China Sky One Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 Digna Biotech SL Company Overview
5.7.1 Digna Biotech SL Pipeline Products & Ongoing Clinical Trials Overview
5.8 Exact Sciences Corp Company Overview
5.8.1 Exact Sciences Corp Pipeline Products & Ongoing Clinical Trials Overview
5.9 Fujirebio Diagnostics Inc Company Overview
5.9.1 Fujirebio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.10 German Cancer Research Center Company Overview
5.10.1 German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview
5.11 Glycotest Inc Company Overview
5.11.1 Glycotest Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 ImCare Biotech LLC Company Overview
5.12.1 ImCare Biotech LLC Pipeline Products & Ongoing Clinical Trials Overview
5.13 Imperial College London Company Overview
5.13.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
5.14 IntegraGen SA Company Overview
5.14.1 IntegraGen SA Pipeline Products & Ongoing Clinical Trials Overview
5.15 Matrix-Bio Inc Company Overview
5.15.1 Matrix-Bio Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 MDNA Life Sciences Inc Company Overview
5.16.1 MDNA Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.17 Medical University of South Carolina Company Overview
5.17.1 Medical University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview
5.18 Medical University of Vienna Company Overview
5.18.1 Medical University of Vienna Pipeline Products & Ongoing Clinical Trials Overview
5.19 Memorial Sloan Kettering Cancer Center Company Overview
5.19.1 Memorial Sloan Kettering Cancer Center Pipeline Products & Ongoing Clinical Trials Overview
5.20 NanoString Technologies Inc Company Overview
5.20.1 NanoString Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.21 Numares AG Company Overview
5.21.1 Numares AG Pipeline Products & Ongoing Clinical Trials Overview
5.22 Oncimmune (USA) LLC Company Overview
5.22.1 Oncimmune (USA) LLC Pipeline Products & Ongoing Clinical Trials Overview
5.23 Orion Genomics LLC Company Overview
5.23.1 Orion Genomics LLC Pipeline Products & Ongoing Clinical Trials Overview
5.24 PleX Diagnostics Inc (Inactive) Company Overview
5.24.1 PleX Diagnostics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.25 ProMIS Neurosciences Inc Company Overview
5.25.1 ProMIS Neurosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.26 Proplex Technologies Llc Company Overview
5.26.1 Proplex Technologies Llc Pipeline Products & Ongoing Clinical Trials Overview
5.27 Proteome Sciences Plc Company Overview
5.27.1 Proteome Sciences Plc Pipeline Products & Ongoing Clinical Trials Overview
5.28 Roche Diagnostics International Ltd Company Overview
5.28.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.29 University of Louisville Company Overview
5.29.1 University of Louisville Pipeline Products & Ongoing Clinical Trials Overview
5.30 University of Rochester Company Overview
5.30.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
5.31 Ventana Medical Systems Inc Company Overview
5.31.1 Ventana Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.32 Viomics Inc. Company Overview
5.32.1 Viomics Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.33 XEPTAGEN SpA Company Overview
5.33.1 XEPTAGEN SpA Pipeline Products & Ongoing Clinical Trials Overview
5.34 Ymir Genomics LLC. Company Overview
5.34.1 Ymir Genomics LLC. Pipeline Products & Ongoing Clinical Trials Overview

6 Liver Cancer Diagnostic Tests - Recent Developments
6.1 Nov 05, 2019: Blueprint Medicines outlines precision therapy research vision, provides update on discovery and clinical-stage portfolio at R&D Day and reports third quarter 2019 financial results
6.2 Oct 31, 2019: Proteome Sciences: Trading update and announcement of Board Changes
6.3 Oct 30, 2019: PerkinElmer announces financial results for the third quarter of 2019
6.4 Oct 29, 2019: Pfizer reports third-quarter 2019 results
6.5 Sep 27, 2019: Ian Read to retire as executive chairman of Pfizer’s board of directors; chief executive Officer Dr. Albert Bourla named chairman
6.6 Sep 05, 2019: Simple CEUS Scan helps diagnose Liver Cancer when MRI is uncertain
6.7 Aug 27, 2019: ProMIS Neurosciences appoints Internationally Recognized Researcher in Alzheimer’s Disease in Down Syndrome Dr. Andre Strydom to its Scientific Advisory Board

7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact Us
7.4 Disclaimer

List of Tables
Table 1: Liver Cancer Diagnostic Tests - Pipeline Products by Stage of Development
Table 2: Liver Cancer Diagnostic Tests - Pipeline Products by Territory
Table 3: Liver Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
Table 4: Liver Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
Table 5: Liver Cancer Diagnostic Tests - Ongoing Clinical Trials
Table 6: Liver Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development
Table 7: Liver Cancer Diagnostic Tests - Pipeline Products by Stage of Development
Table 8: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
Table 9: ARCHITECT c16000 System - PIVKA Assay - Product Status
Table 10: ARCHITECT c16000 System - PIVKA Assay - Product Description
Table 11: ARCHITECT c4000 System - PIVKA Assay - Product Status
Table 12: ARCHITECT c4000 System - PIVKA Assay - Product Description
Table 13: ARCHITECT c8000 System - PIVKA Assay - Product Status
Table 14: ARCHITECT c8000 System - PIVKA Assay - Product Description
Table 15: ARCHITECT ci16200 Integrated System - PIVKA Assay - Product Status
Table 16: ARCHITECT ci16200 Integrated System - PIVKA Assay - Product Description
Table 17: ARCHITECT ci4100 Integrated System - PIVKA Assay - Product Status
Table 18: ARCHITECT ci4100 Integrated System - PIVKA Assay - Product Description
Table 19: ARCHITECT ci8200 Integrated System - PIVKA Assay - Product Status
Table 20: ARCHITECT ci8200 Integrated System - PIVKA Assay - Product Description
Table 21: ARCHITECT i4000SR System - PIVKA II Assay - Product Status
Table 22: ARCHITECT i4000SR System - PIVKA II Assay - Product Description
Table 23: Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Biomarker Test - Liver Cancer Diagnostic Tests - Product Status
Table 25: Biomarker Test - Liver Cancer Diagnostic Tests - Product Description
Table 26: AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Multiplexed Detection - Des-Carboxy Prothrombin - Product Status
Table 28: Multiplexed Detection - Des-Carboxy Prothrombin - Product Description
Table 29: Multiplexed Detection - Matrix metalloproteinase 1 - Product Status
Table 30: Multiplexed Detection - Matrix metalloproteinase 1 - Product Description
Table 31: Multiplexed Detection - Procollagen type III N-terminal peptide - Product Status
Table 32: Multiplexed Detection - Procollagen type III N-terminal peptide - Product Description
Table 33: BioMark Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Biomarker Assay - Hepatocellular Cancer - Product Status
Table 35: Biomarker Assay - Hepatocellular Cancer - Product Description
Table 36: Bioprognos SL Pipeline Products & Ongoing Clinical Trials Overview
Table 37: MBDAA Liver Cancer Test - Product Status
Table 38: MBDAA Liver Cancer Test - Product Description
Table 39: China Sky One Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Diagnostic Kit - Liver Cancer Diagnostic Tests - Product Status
Table 41: Diagnostic Kit - Liver Cancer Diagnostic Tests - Product Description
Table 42: Digna Biotech SL Pipeline Products & Ongoing Clinical Trials Overview
Table 43: HCC Molecular Marker Assay - Product Status
Table 44: HCC Molecular Marker Assay - Product Description
Table 45: Oxidated APO-A1 Assay - Product Status
Table 46: Oxidated APO-A1 Assay - Product Description
Table 47: Exact Sciences Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 48: Blood-based Liver Cancer Test - Product Status
Table 49: Blood-based Liver Cancer Test - Product Description
Table 50: DNA Biomarkers - Hepatocellular Carcinoma - Product Status
Table 51: DNA Biomarkers - Hepatocellular Carcinoma - Product Description
Table 52: Fujirebio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 53: Lumipulse G - PIVKA-II Assay - Product Status
Table 54: Lumipulse G - PIVKA-II Assay - Product Description
Table 55: German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview
Table 56: RAGE Based Diagnostic Assay - Liver Cancer Diagnostic Tests - Product Status
Table 57: RAGE Based Diagnostic Assay - Liver Cancer Diagnostic Tests - Product Description
Table 58: Glycotest Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 59: HCC Panel - Product Status
Table 60: HCC Panel - Product Description

List of Figures
Figure 1: Liver Cancer Diagnostic Tests - Pipeline Products by Stage of Development
Figure 2: Liver Cancer Diagnostic Tests - Pipeline Products by Territory
Figure 3: Liver Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
Figure 4: Liver Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
Figure 5: Liver Cancer Diagnostic Tests - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Abbott Diagnostics
  • Abcodia Ltd
  • AXO Science SAS
  • BioMark Technologies Inc
  • Bioprognos SL
  • China Sky One Medical Inc
  • Digna Biotech SL
  • Exact Sciences Corp
  • Fujirebio Diagnostics Inc
  • German Cancer Research Center
  • Glycotest Inc
  • ImCare Biotech LLC
  • Imperial College London
  • IntegraGen SA
  • Matrix-Bio Inc
  • MDNA Life Sciences Inc
  • Medical University of South Carolina
  • Medical University of Vienna
  • Memorial Sloan Kettering Cancer Center
  • NanoString Technologies Inc
  • Numares AG
  • Oncimmune (USA) LLC
  • Orion Genomics LLC
  • ProMIS Neurosciences Inc
  • Proplex Technologies Llc
  • Proteome Sciences Plc
  • Roche Diagnostics International Ltd
  • University of Louisville
  • University of Rochester
  • Ventana Medical Systems Inc
  • Viomics Inc.
  • XEPTAGEN SpA
  • Ymir Genomics LLC.
Note: Product cover images may vary from those shown
Adroll
adroll